Weiguo Dai is currently a Fellow at Johnson & Johnson Pharmaceutical Research and Development. He is also an Adjunct Professor in Thomas J. Long School of Pharmacy and Health Sciences at University of the Pacific in California, Stockton, CA, USA. At Johnson & Johnson, he has been leading efforts in the development of new drug delivery technology and external technology assessment. Dr. Dai earned his Ph.D. degree in chemical engineering from The Johns Hopkins University in 1996 and has over 16 years of drug product development experience in biotech/pharmaceutical companies, including Guilford Pharmaceuticals (now Eisai), Amgen, and ALZA/Johnson & Johnson. Dr. Dai was Director of pharmaceutical science at Landec Corporation before he rejoined Johnson & Johnson in 2008. Dr. Dai has authored or coauthored over 40 peer-reviewed original journal publications. He currently serves on the editorial advisory board of 2 pharmaceutical journals and has been invited as reviewer for a number of international refereed journals in drug delivery and pharmaceutical science. Dr. Dai has also been a Frequent Invited Speaker and Chair in international conferences/workshops such as AAPS, NBC, and CRS. His research interests include combination drug product development for both biologics and small molecules using conventional and nonconventional techniques and strategies.
Biography Updated on 8 March 2012